HomeNewsBusinessEarningsEvaluating opportunities for acquisitions in pharma space: PI Industries

Evaluating opportunities for acquisitions in pharma space: PI Industries

PI Industries has posted a muted set of earnings in Q3. The management though expects a revival in demand from the second half of FY19. In an interview to CNBC-TV8, Mayank Singhal, MD & CEO of the company gave more details on the guidance.

February 20, 2018 / 14:08 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

PI Industries has posted a muted set of earnings in Q3. The management though expects a revival in demand from the second half of FY19. In an interview to CNBC-TV8, Mayank Singhal, MD & CEO of the company gave more details on the guidance.

Singhal said that the product mix has impacted the margin in Q3 of FY18.

Story continues below Advertisement

He further said that we expect margin to stabilise in second half of FY19.

We will maintain margin at current levels going ahead, he added.